Cargando…
Response to: Estimated direct costs of non‐small cell lung cancer by stage at diagnosis and disease management phase: A whole‐disease model
Autores principales: | Jiang, Lisha, Zhou, Kun, Che, Guowei, Ma, Hongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919165/ https://www.ncbi.nlm.nih.gov/pubmed/33410286 http://dx.doi.org/10.1111/1759-7714.13801 |
Ejemplares similares
-
Estimated direct costs of non‐small cell lung cancer by stage at diagnosis and disease management phase: A whole‐disease model
por: Buja, Alessandra, et al.
Publicado: (2020) -
Pivotal role of video‐assisted thoracoscopic surgery in improving survival outcome of stage I non‐small cell lung cancer in day surgery patients
por: Jiang, Lisha, et al.
Publicado: (2021) -
Perioperative preparation in thoracic day surgery: Battle against COVID‐19
por: Shen, Cheng, et al.
Publicado: (2020) -
Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States
por: DeFlorio-Barker, Stephanie, et al.
Publicado: (2021) -
A few comments about the evaluation for small and diminutive colorectal polyps in end-stage renal disease patients
por: Lei, Tiantian, et al.
Publicado: (2022)